Tyra Biosciences, Inc. (TYRA) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 176 transactions totaling $64.3M, demonstrating a bullish sentiment with $19.0M in net insider flow. The most recent transaction on Dec 19, 2025 involved a sale of 10,000 shares valued at $250.0K.
No significant insider buying has been recorded for TYRA in the recent period.
No significant insider selling has been recorded for TYRA in the recent period.
Based on recent SEC filings, insider sentiment for TYRA is bullish with an Insider Alignment Score of 65/100 and a net flow of $19.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Tyra Biosciences, Inc. (TYRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading TYRA stock, having executed 176 transactions in the past 90 days. The most active insider is Rajeev M. Shah (Executive), who has made 1 transactions totaling $41.4M.
Get notified when executives and directors at TYRA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | J. More Robert | Executive | Sale | 10,000 | $25.00 | $250.0K | |
| Dec 12, 2025 | Bensen Daniel | Executive | Sale | 8,000 | $22.64 | $181.1K | |
| Nov 21, 2025 | J. More Robert | Executive | Sale | 246,871 | $20.25 | $5.0M | Large |
| Nov 19, 2025 | Bensen Daniel | Executive | Sale | 49,956 | $16.32 | $815.3K | Large |
| Nov 18, 2025 | Bensen Daniel | Executive | Sale | 75,633 | $16.07 | $1.2M | Large |
| Nov 17, 2025 | Bensen Daniel | Executive | Sale | 18,572 | $16.11 | $299.2K | |
| Nov 17, 2025 | Bensen Daniel | Executive | Sale | 1,500 | $17.07 | $25.6K | |
| Nov 14, 2025 | Bensen Daniel | Executive | Sale | 110,228 | $16.02 | $1.8M | Large |
| Nov 13, 2025 | Bensen Daniel | Executive | Sale | 1,111 | $16.00 | $17.8K | |
| Sep 15, 2025 | Fuhrman Alan | Executive | Award | 701 | $9.13 | $6.4K | |
| Sep 25, 2024 | Harris Todd | Executive | Sale | 600 | $24.01 | $14.4K | 10b5-1 |
| Sep 24, 2024 | Harris Todd | Executive | Sale | 1,055 | $24.02 | $25.3K | 10b5-1 |
| Sep 23, 2024 | Harris Todd | Executive | Sale | 10,092 | $24.13 | $243.5K | 10b5-1 |
| Sep 20, 2024 | Harris Todd | Executive | Sale | 7,109 | $24.19 | $172.0K | 10b5-1 |
| Sep 19, 2024 | Harris Todd | Executive | Sale | 5,671 | $24.30 | $137.8K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 23 | $42.5M | 39.7% |
Purchase(P) | 6 | $41.6M | 38.9% |
Sale(S) | 88 | $22.7M | 21.2% |
Exercise(M) | 39 | $264.6K | 0.2% |
Gift(G) | 2 | $0 | 0.0% |
Conversion(C) | 18 | $0 | 0.0% |
Insiders at Tyra Biosciences, Inc. are accumulating shares at an accelerated pace. With 20 insiders making 176 transactions totaling $41.6M in purchases versus $22.7M in sales, the net buying activity of $19.0M signals strong executive confidence. Rajeev M. Shah (Executive) leads the buying activity with $41.4M in transactions across all time.